Siltussin SA

Product NDC
54838-117
Requested package NDC
54838-117-40
11-digit product format
548380117
Labeler code
54838
Product ID
54838-117_0c91f982-f8fd-450c-86eb-3f49f4ef11d5
Type
HUMAN OTC DRUG
Nonproprietary name
Guaifenesin
Dosage form
LIQUID
Route
ORAL
Labeler
Lannett Company, Inc.
Application
part341
Marketing category
OTC MONOGRAPH FINAL
Marketing start
1998-10-05
Marketing end
2024-12-31
Substance
GUAIFENESIN
Active strength
100 mg/5mL
Pharmacologic classes
Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]
NDC exclude flag
No
Listing certified through
0000-00-00
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded packagepackage54838-11754838-117-40DDiscontinued by firm2026-10-12

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 9 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Snapshot, Source SHA-256 table
Captured / source dateSnapshotSource SHA-256
2025-12-14 17:58 UTC · source 2025-12-05d630ba8d3edf…732f749b63fb…
2025-08-27 00:01 UTC · source 2025-08-26f5e01cc5f278…a2eaf40c39c3…
2025-04-01 02:39 UTC · source 2025-03-312ef7874e63bc…57b86245f4fa…
2025-03-28 20:22 UTC · source 2025-03-28a1b67e2a42f9…c4cf2c586c0d…
2025-03-22 03:12 UTC · source 2025-03-21cfe11265f3b6…090c488252e2…
2025-03-10 12:48 UTC · source 2025-03-10cdf11ea48f46…ba0047e9e063…
2025-02-02 03:52 UTC · source 2025-01-31302b2466d912…e7b80fea0513…
2025-01-20 13:05 UTC · source 2025-01-20ed331223b511…672a5bd82f5f…
2025-01-11 03:41 UTC · source 2025-01-100efc9e666f02…f202fb6c5f17…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
54838-117-40ML - Milliliter54838-11767b52498-6546-4e63-a255-54d3a07968f312012-07-24
54838-117-70ML - Milliliter54838-117b9e02fd7-11f9-44a1-8caa-3f51ff5ce36d12012-07-24
54838-117-80ML - Milliliter54838-117fb019950-f868-4d0d-9450-9155bebd5a8112012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
GuaifenesinACTIVE INGREDIENT495W7451VQSILTUSSIN SA (GUAIFENESIN) LIQUID [SILARX PHARMACEUTICALS, INC]15
GuaifenesinACTIVE MOIETY495W7451VQSILTUSSIN SA (GUAIFENESIN) LIQUID [SILARX PHARMACEUTICALS, INC]15
anhydrous citric acidINACTIVE INGREDIENTXF417D3PSLSILTUSSIN SA (GUAIFENESIN) LIQUID [SILARX PHARMACEUTICALS, INC]15
D&C yellow no. 10INACTIVE INGREDIENT35SW5USQ3GSILTUSSIN SA (GUAIFENESIN) LIQUID [SILARX PHARMACEUTICALS, INC]15
FD&C blue no. 1INACTIVE INGREDIENTH3R47K3TBDSILTUSSIN SA (GUAIFENESIN) LIQUID [SILARX PHARMACEUTICALS, INC]15
FD&C red no. 40INACTIVE INGREDIENTWZB9127XOASILTUSSIN SA (GUAIFENESIN) LIQUID [SILARX PHARMACEUTICALS, INC]15
glycerinINACTIVE INGREDIENTPDC6A3C0OXSILTUSSIN SA (GUAIFENESIN) LIQUID [SILARX PHARMACEUTICALS, INC]15
propylene glycolINACTIVE INGREDIENT6DC9Q167V3SILTUSSIN SA (GUAIFENESIN) LIQUID [SILARX PHARMACEUTICALS, INC]15
saccharin sodium dihydrateINACTIVE INGREDIENTSB8ZUX40TYSILTUSSIN SA (GUAIFENESIN) LIQUID [SILARX PHARMACEUTICALS, INC]15
sodium benzoateINACTIVE INGREDIENTOJ245FE5EUSILTUSSIN SA (GUAIFENESIN) LIQUID [SILARX PHARMACEUTICALS, INC]15
sodium citrateINACTIVE INGREDIENT1Q73Q2JULRSILTUSSIN SA (GUAIFENESIN) LIQUID [SILARX PHARMACEUTICALS, INC]15
sorbitolINACTIVE INGREDIENT506T60A25RSILTUSSIN SA (GUAIFENESIN) LIQUID [SILARX PHARMACEUTICALS, INC]15
waterINACTIVE INGREDIENT059QF0KO0RSILTUSSIN SA (GUAIFENESIN) LIQUID [SILARX PHARMACEUTICALS, INC]15
GuaifenesinACTIVE INGREDIENT495W7451VQSILTUSSIN SA (GUAIFENESIN) LIQUID [PREFERRED PHARMACEUTICALS, INC]1
GuaifenesinACTIVE INGREDIENT495W7451VQSILTUSSIN SA (GUAIFENESIN) LIQUID [PROFICIENT RX LP]1
GuaifenesinACTIVE MOIETY495W7451VQSILTUSSIN SA (GUAIFENESIN) LIQUID [PROFICIENT RX LP]1
GuaifenesinACTIVE MOIETY495W7451VQSILTUSSIN SA (GUAIFENESIN) LIQUID [PREFERRED PHARMACEUTICALS, INC]1
anhydrous citric acidINACTIVE INGREDIENTXF417D3PSLSILTUSSIN SA (GUAIFENESIN) LIQUID [PREFERRED PHARMACEUTICALS, INC]1
anhydrous citric acidINACTIVE INGREDIENTXF417D3PSLSILTUSSIN SA (GUAIFENESIN) LIQUID [PROFICIENT RX LP]1
D&C yellow no. 10INACTIVE INGREDIENT35SW5USQ3GSILTUSSIN SA (GUAIFENESIN) LIQUID [PREFERRED PHARMACEUTICALS, INC]1
D&C yellow no. 10INACTIVE INGREDIENT35SW5USQ3GSILTUSSIN SA (GUAIFENESIN) LIQUID [PROFICIENT RX LP]1
FD&C blue no. 1INACTIVE INGREDIENTH3R47K3TBDSILTUSSIN SA (GUAIFENESIN) LIQUID [PROFICIENT RX LP]1
FD&C blue no. 1INACTIVE INGREDIENTH3R47K3TBDSILTUSSIN SA (GUAIFENESIN) LIQUID [PREFERRED PHARMACEUTICALS, INC]1
FD&C red no. 40INACTIVE INGREDIENTWZB9127XOASILTUSSIN SA (GUAIFENESIN) LIQUID [PROFICIENT RX LP]1
FD&C red no. 40INACTIVE INGREDIENTWZB9127XOASILTUSSIN SA (GUAIFENESIN) LIQUID [PREFERRED PHARMACEUTICALS, INC]1
glycerinINACTIVE INGREDIENTPDC6A3C0OXSILTUSSIN SA (GUAIFENESIN) LIQUID [PREFERRED PHARMACEUTICALS, INC]1
glycerinINACTIVE INGREDIENTPDC6A3C0OXSILTUSSIN SA (GUAIFENESIN) LIQUID [PROFICIENT RX LP]1
propylene glycolINACTIVE INGREDIENT6DC9Q167V3SILTUSSIN SA (GUAIFENESIN) LIQUID [PREFERRED PHARMACEUTICALS, INC]1
propylene glycolINACTIVE INGREDIENT6DC9Q167V3SILTUSSIN SA (GUAIFENESIN) LIQUID [PROFICIENT RX LP]1
saccharin sodiumINACTIVE INGREDIENTSB8ZUX40TYSILTUSSIN SA (GUAIFENESIN) LIQUID [PREFERRED PHARMACEUTICALS, INC]1
SACCHARIN SODIUMINACTIVE INGREDIENTSB8ZUX40TYSILTUSSIN SA (GUAIFENESIN) LIQUID [PROFICIENT RX LP]1
sodium benzoateINACTIVE INGREDIENTOJ245FE5EUSILTUSSIN SA (GUAIFENESIN) LIQUID [PROFICIENT RX LP]1
sodium benzoateINACTIVE INGREDIENTOJ245FE5EUSILTUSSIN SA (GUAIFENESIN) LIQUID [PREFERRED PHARMACEUTICALS, INC]1
sodium citrateINACTIVE INGREDIENT1Q73Q2JULRSILTUSSIN SA (GUAIFENESIN) LIQUID [PREFERRED PHARMACEUTICALS, INC]1
sodium citrateINACTIVE INGREDIENT1Q73Q2JULRSILTUSSIN SA (GUAIFENESIN) LIQUID [PROFICIENT RX LP]1
sorbitolINACTIVE INGREDIENT506T60A25RSILTUSSIN SA (GUAIFENESIN) LIQUID [PREFERRED PHARMACEUTICALS, INC]1
sorbitolINACTIVE INGREDIENT506T60A25RSILTUSSIN SA (GUAIFENESIN) LIQUID [PROFICIENT RX LP]1
waterINACTIVE INGREDIENT059QF0KO0RSILTUSSIN SA (GUAIFENESIN) LIQUID [PROFICIENT RX LP]1
waterINACTIVE INGREDIENT059QF0KO0RSILTUSSIN SA (GUAIFENESIN) LIQUID [PREFERRED PHARMACEUTICALS, INC]1

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
54838-117-4054838011740118 mL in 1 BOTTLE, PLASTIC (54838-117-40) 118 ml1998-10-052024-12-31NoNoCurrent